| Name | OTS514 hydrochloride |
| Description | OTS514 hydrochloride is a highly effective TOPK(T-LAK cell-originated protein kinase) inhibitor (IC50: 2.6 nM). |
| Cell Research | Cell lines: CD34+ HSCs. Concentrations: 20 or 40 nM. Incubation Time: 48 h. Method: Cells were cultured in RPMI supplemented with 20% fetal bovine serum and 1×StemSpan CC100.Cells were treated with OTS514 (20 or 40 nM) or OTS964 (100 or 200 nM) for 48 hours.Collected cells were washed with PBS and resuspended in 100 ml of PBS followed by staining with CD41a antibody for 20 min at room temperature.Finally,the cells were washed with PBS again and then analyzed for CD41a staining by flow cytometry.Expression of STAT5 was examined by Western blot with an anti-STAT5 antibody. |
| Animal Research | Animal: BALB/cSLC-nu/nu mice. Solvent: 5% glucose (i.v.); 0.5% methylcellulose (p.o.). Dosages: 1,2.5,and 5 mg/kg |
| In vitro | OTS514 can inhibit the growth of kidney cancer cell lines (VMRC-RCW, Caki-1, Caki-2, 769-P, and 786-O), in which TOPK was highly expressed (IC50:19.9-44.1 nM)[1]. OTS514 markedly inhibits the growth of TOPK-positive cancer cells. It also shows the significant growth-inhibitory effect on ovarian cancer cell lines (IC50: 3.0-46 nM)[3]. |
| In vivo | In mouse xenograft studies with human lung cancer cells, OTS514 shows certain efficacy but also caused severe hematopoietic toxicity (reduction of red blood cells and white blood cells associated with marked increase in platelets)[2]. Compared with vehicle control (P < 0.001), OTS514 (p.o.) significantly elongated overall survival in the ES-2 abdominal dissemination xenograft model. |
| Storage | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 27.5 mg/mL (68.59 mM), Sonication is recommended.
|
| Keywords | TOPK | positive | OTS-514 Hydrochloride | OTS514 Hydrochloride | OTS-514 | OTS514 | OTS 514 Hydrochloride | OTS 514 | myeloma | multiple | Inhibitor | inhibit | HMCL | cycle | cell | cancer | arrest | Apoptosis |
| Inhibitors Related | Stavudine | Aceglutamide | Urea | Tamoxifen | Cysteamine hydrochloride | Metronidazole | Citric Acid Triammonium | Formamide | Dimethyl phthalate | Alginic acid | Sodium Molybdate | Sildenafil citrate |
| Related Compound Libraries | Apoptosis Compound Library | Pain-Related Compound Library | Bioactive Compound Library | HIF-1 Signaling Pathway Compound Library | Kinase Inhibitor Library | Hematonosis Compound Library | Inhibitor Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | Preclinical Compound Library | Anti-Liver Cancer Compound Library | Anti-Cancer Active Compound Library |
United States
